RCUS Arcus Biosciences, Inc.
Healthcare$24.13+2.99%ClosedMarket Cap: $2.43B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$31.17
Target (Median)
$30.00
Target Range
$22.00 - $47.00
Upside from current price: 29.2%
Rating Distribution
0 Strong Buy9 Buy3 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-11 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| 2026-05-07 | Goldman Sachs | maintain | Buy | Buy |
| 2026-04-02 | Wedbush | maintain | Outperform | Outperform |
| 2026-03-05 | Citigroup | maintain | Buy | Buy |
| 2026-03-02 | Leerink Partners | maintain | Outperform | Outperform |
| 2026-03-02 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-02-12 | Wells Fargo | downgrade | Equal Weight | Overweight |
| 2026-01-13 | Goldman Sachs | upgrade | Buy | Neutral |
| 2026-01-08 | Morgan Stanley | downgrade | Equal Weight | Overweight |
| 2025-12-12 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-3.32 | $95.3M | 7 |
| Sun Dec 31 | $-2.16 | $177.8M | 8 |
| Mon Dec 31 | $-0.84 | $423.5M | 6 |
| Tue Dec 31 | $1.61 | $913.2M | 6 |